The CTC identification criteria were as follows (Figure 1A): nuclear DAPI+, CD45‐, CD31‐, chromosome 8 (CEP8) aneuploidy positive, and CTC tumor marker positive or negative. This evidence concerns the gene PECAM1 and neoplasm.